Medical Condition News

RSS

Study links urogenital birth defects with DDT

Women who lived in villages sprayed with DDT to reduce malaria gave birth to 33 per cent more baby boys with urogenital birth defects (UGBD) between 2004 and 2006 than women in unsprayed villages, according to research published online by the UK-based urology journal BJUI.

24 Oct 2009

Cohen Independent Research Group publishes a report profiling Nutra Pharma

Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that Cohen Independent Research Group has published a report profiling Nutra Pharma Corporation.

24 Oct 2009

Dr. Anthony Falcon: We're facing a catastrophic situation on the border

Kaiser Health News staff writer Jessica Marcy talks with Dr. Antonio Falcon, a physician in the border town of Rio Grande City, Texas. He explained his concern "about several health threats facing border communities, including tuberculosis, diabetes, obesity and the H1N1 virus that causes swine flu."

24 Oct 2009

2009 Inspiration Gala raises $1.27 million for BC Cancer Foundation

The 2009 Inspiration Gala raised $1.27 million for the BC Cancer Foundation and colorectal cancer research at the BC Cancer Agency last night, as nearly 400 guests dined and donated during the emotion-filled, sold-out event.

24 Oct 2009

Sickle cell disease can be treated with resveratrol extract, according to researchers

An extract in red grape skin may be a new treatment for sickle cell disease, Medical College of Georgia researchers say.

23 Oct 2009

Modified NAGA: New enzyme for enzyme replacement therapy

A new study uses a creative structure-based remodeling strategy to design a therapeutic protein that exhibits significant advantages over currently available treatments for a rare disease that often leads to cardiac and renal failure. The research, published by Cell Press on October 22nd in the American Journal of Human Genetics, describes a new and highly promising candidate for enzyme replacement therapy (ERT) for Fabry disease.

23 Oct 2009

Follow healthy lifestyle to overturn genetic predisposition to heart disease

When it comes to heart disease, lifestyle usually trumps genetics, says noted genetic researcher Dr. Robert Hegele, Heart and Stroke Foundation of Canada Lecturer at the Canadian Cardiovascular Congress 2009.

23 Oct 2009

Study compares differences between inpatient and day treatment of bulimia nervosa

A German study published in the fifth issue of Psychotherapy and Psychosomatics compares the differences between inpatient and day treatment of bulimia nervosa.

23 Oct 2009

Workers with MetS can cost employers up to $5,867 in health care annually: Study

Someone healthy enough to work could still cost an employer more than $4,000 annually in unnecessary health care costs.

23 Oct 2009

Tips to prevent allergy during Halloween

The haunted happenings of Halloween are upon us and soon we'll be carving pumpkins, dressing in costumes and telling spooky stories. But if your child has a food allergy, what's at the bottom of his or her trick-or-treat bag may be more frightening than any ghost or goblin.

23 Oct 2009

The 23rd annual Alternatives conference to be held in Nebraska

The 23rd annual Alternatives conference, the only national mental health conference organized by and for mental health consumers/survivors, will be held October 28 to November 1, 2009, at the Hilton Omaha, 1001 Cass Street, in Omaha, Nebraska.

23 Oct 2009

Shire announces new pharmacokinetic data of ADHD medication

Shire plc, the global specialty biopharmaceutical company, announced new data about the pharmacokinetics of its Attention-Deficit/Hyperactivity Disorder (ADHD) medication, Vyvanse- (lisdexamfetamine dimesylate) Capsules CII, which showed that Vyvanse provided similar concentrations of its active medication in the blood when administered either intranasally or when administered orally.

23 Oct 2009

DDT exposure is associated with urogenital birth defects in newborn boys

23 Oct 2009

Exposing pregnant women to chemotherapy does not affect the foetus

Professor Frederic Amant of the Katholieke Universiteit Leuven (K.U.Leuven) directs research into the treatment of cancer in pregnant women and the consequences of such treatment on foetal development. In her PhD dissertation on chemotherapy during pregnancy, Kristel Van Calsteren presents new scientific discoveries.

23 Oct 2009

Boehringer Ingelheim receives European CHMP positive opinion for MICARDIS

Boehringer Ingelheim announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Evaluation Agency (EMEA) has issued a positive opinion for the approval of MICARDIS® (telmisartan) for the reduction of cardiovascular morbidity.

23 Oct 2009

Verizon Foundation awards $10,000 grant to The Wellness Community of the East Bay

The Wellness Community of the East Bay has been awarded a $10,000 grant from the Verizon Foundation, the philanthropic arm of Verizon, to fund the use of technology to identify the best community-based psychological and social support and education strategies for cancer patients and their families.

23 Oct 2009

Study shows appropriate use of CRRT improves AKI patient outcomes

A study appearing today in the New England Journal of Medicine adds to the growing body of evidence supporting continuous renal replacement therapy (CRRT) as the therapy of choice for treatment of acute kidney injury (AKI) patients in the intensive care unit (ICU).

23 Oct 2009

Number of diabetic patients on the rise; figures could reach to 440 million by 2030

Newly published data from the International Diabetes Federation (IDF) show that number of people with diabetes continues to grow unchecked. The figures reveal that, if action is not taken to change the path of the epidemic, the numbers of people with diabetes will be close to 440 million by 2030.

23 Oct 2009

Decision Resources predicts TNF-alpha inhibitors to dominate rheumatoid arthritis treatment

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that tumor necrosis factor (TNF)-alpha inhibitors will continue to dominate first- and second-line biologic therapy for the treatment of rheumatoid arthritis in the United States through 2011, but the more established branded drugs such as, Centocor Ortho Biotech's Remicade, Abbott's Humira and Amgen/Wyeth's Enbrel, in this class will face competition from newer entrants.

23 Oct 2009

Community based initiative to help combat obesity and promote healthy lifestyles

President Bill Clinton made a special appearance on October 10 to open the Weight Watchers Presents Fun and Fit in the City -- at the Harlem Children's Zone in Harlem, NY. Part of the Food Network New York City Wine & Food Festival, the free community based initiative -- which drew over 800 attendees -- was created to help combat obesity and provide practical tips for families to follow healthier lifestyles.

23 Oct 2009

Medical Condition News

Study links urogenital birth defects with DDT

Cohen Independent Research Group publishes a report profiling Nutra Pharma

Dr. Anthony Falcon: We're facing a catastrophic situation on the border

2009 Inspiration Gala raises $1.27 million for BC Cancer Foundation

Sickle cell disease can be treated with resveratrol extract, according to researchers

Modified NAGA: New enzyme for enzyme replacement therapy

Follow healthy lifestyle to overturn genetic predisposition to heart disease

Study compares differences between inpatient and day treatment of bulimia nervosa

Workers with MetS can cost employers up to $5,867 in health care annually: Study

Tips to prevent allergy during Halloween

The 23rd annual Alternatives conference to be held in Nebraska

Shire announces new pharmacokinetic data of ADHD medication

DDT exposure is associated with urogenital birth defects in newborn boys

Exposing pregnant women to chemotherapy does not affect the foetus

Boehringer Ingelheim receives European CHMP positive opinion for MICARDIS

Verizon Foundation awards $10,000 grant to The Wellness Community of the East Bay

Study shows appropriate use of CRRT improves AKI patient outcomes

Number of diabetic patients on the rise; figures could reach to 440 million by 2030

Decision Resources predicts TNF-alpha inhibitors to dominate rheumatoid arthritis treatment

Community based initiative to help combat obesity and promote healthy lifestyles

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News